Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyBlue Cross Blue Shield - Nerve Fiber Density Cover…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - OklahomaPolicy CPCPLABO64

    Nerve Fiber Density Testing

    Customize your policy alerts

    Sign up for Blue Cross Blue Shield - Oklahoma Policy CPCPLABO64 alerts

    Get alerted when Policy CPCPLABO64 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs reimbursement criteria for epidermal nerve fiber density measurement (skin biopsy) for diagnosis of small-fiber neuropathy for Blue Cross Blue Shield of Oklahoma members and providers.

    Policy Summary
    PayerBlue Cross Blue Shield - Oklahoma
    PolicyNerve Fiber Density Testing
    Policy CodePolicy CPCPLABO64
    Change TypeClarifiedRevisedAdded
    Effective DateJan 15, 2025
    Last ReviewOct 30, 2024
    Next Review Date
    Key ActionProviders must submit accurate documentation for services and may be asked to provide additional records during claim review.
    SourceLink
    POLICY UPDATE CHANGES

    Document updated with literature review; Reimbursement Information unchanged; References revised.

    Reimbursement Information revised for clarity and code list updated: added code 88313; removed codes 88305 and 88314.

    New policy established on 11/01/2022.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    6
    procedure codes listed
    ALLcriteria required for reimbursement
    SGNFDexplicitly not reimbursable
    3update history entries

    Reimbursement Criteria

    Reimbursement criteria for ENFD testing

    For diagnosis of small-fiber neuropathy, epidermal nerve fiber density measurement from a skin biopsy may be reimbursable when ALL of the following are met:

    ALL of the following

    • Individual presents with symptoms of painful sensory neuropathy
    • No history of a disorder known to predispose to painful neuropathy (examples include diabetic neuropathy, toxic neuropathy, HIV neuropathy, celiac neuropathy, inherited neuropathy)
    • Physical examination shows no evidence of large-fiber neuropathy (eg, no reduced or absent muscle-stretch reflexes; no reduced proprioception or vibration sensation)
    • Electromyography and nerve-conduction studies are normal and show no evidence of large-fiber neuropathy

    ALL of the following

    • For all other situations not described above, epidermal nerve fiber density measurement from a skin biopsy is not reimbursable
    • Measurement of sweat gland nerve fiber density is not reimbursable

    Applicable Codes and Coding Rules

    Listed pathology/histology codesCPTCovered
    88313
    88341
    88342
    88344
    88346
    88350
    88356
    Notesmixed
    N/AThe following is not an all-encompassing code list: The inclusion of a code does not guarantee it is a covered service or eligible for reimbursement.
    Reimbursement condition requirement
    Reimbursement requirementEpidermal nerve fiber density measurement from a skin biopsy may be reimbursable only when ALL listed clinical conditions are met: symptoms of painful sensory neuropathy; no history of disorders known to predispose to painful neuropathy; physical exam shows no evidence of large-fiber neuropathy; electromyography and nerve-conduction studies normal with no evidence of large-fiber neuropathy.
    ScopeApplies to diagnosis of small-fiber neuropathy only; other situations are not reimbursable.
    ExclusionsMeasurement of sweat gland nerve fiber density is not reimbursable.

    Documentation & Claim Submission

    Documentation Required

    Documentation and claim submission responsibilities

    Providers are responsible for submission of accurate documentation of services performed and must submit claims using valid code combinations from HIPAA-approved code sets. Claims are subject to review against benefit coverage, provider contract language, medical policies, clinical payment and coding policies, and coding edit protocols; upon request, the provider is urged to submit any additional documentation to support the claim.

    • Submit claims coded per industry standard coding guidelines (eg, CPT, HCPCS, ICD-10-CM/PCS, NDC, DRG) and applicable coding authorities.
    • Be prepared to provide additional records or documentation upon request for claim review and adjudication.
    • Claims may be reviewed against plan documents and provider contracts; plan documents govern coverage conflicts.

    Key Definitions

    ENFD (epidermal nerve fiber density) testing
    DefinitionEpidermal nerve fiber density (ENFD) testing is the measurement of epidermal nerve fiber density from a skin biopsy used in evaluation for small-fiber neuropathy.
    IndicationMay be reimbursable when performed to diagnose small-fiber neuropathy and all clinical criteria in the policy are met.
    Relation to other testsRequired complementary findings: normal electromyography and nerve-conduction studies demonstrating no large-fiber neuropathy.
    SGNFD (sweat gland nerve fiber density)
    Policy statementMeasurement of sweat gland nerve fiber density (SGNFD) is explicitly not reimbursable under this policy.
    ContextSGNFD is listed as an exclusion separate from ENFD testing; claims for SGNFD should not be reimbursed.
    Policy Summary
    PayerBlue Cross Blue Shield - Oklahoma
    PolicyNerve Fiber Density Testing
    Policy CodePolicy CPCPLABO64
    Change TypeClarifiedRevisedAdded
    Effective DateJan 15, 2025
    Last ReviewOct 30, 2024
    Next Review Date
    Key ActionProviders must submit accurate documentation for services and may be asked to provide additional records during claim review.
    SourceLink
    On This Page
    Reimbursement CriteriaApplicable Codes and Coding RulesDocumentation & Claim SubmissionKey Definitions
    Implication for coding/claimsDo not submit or expect reimbursement for procedures described as measurement of sweat gland nerve fiber density under this policy.